Cytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Drugs

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Research
Other Health
Pharmaceutical
Oncology
Other Manufacturing
Science
Cardiology
Chemicals/Plastics
Biotechnology
Health
Diabetes
Other Science
Manufacturing
Cytovance Biologics

More Like This

PR Newswire associated0

Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing

Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development

Biesterfeld and Celanese: global expansion and enhanced joint portfolio as of 2024

PR Newswire associated0

Cambrex Announces New Liquid-Phase Peptide Synthesis Manufacturing Technology

PR Newswire associated0

LenioBio Collaborates with ReciBioPharm to Scale Up ALiCE® Technology and Expedite Vaccine Production

PR Newswire associated0

Peptone Expands Leadership Team with Key Executive Hires

Business Wire logo

Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement

Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors. (Graphic: Business Wire)

Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors